Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger E Thomas

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Current Aging Science|February 23, 2016
Assessing Medication Problems in those ≥ 65 Using the STOPP and START CriteriaRoger E Thomas
Vaccine|May 13, 2016
Do we have enough evidence how seasonal influenza is transmitted and can be prevented in hospitals to implement a comprehensive policy?Roger E Thomas
Journal of Travel Medicine|October 30, 2013
Can the safety of the yellow fever vaccine be evaluated by a retrospective study of databases?Roger E Thomas
Drug Design, Development and Therapy|October 28, 2016
Yellow fever vaccine-associated viscerotropic disease: current perspectivesRoger E Thomas
American Journal of Public Health|November 7, 2019
Roger E. Thomas CommentsRoger E Thomas
Annals of Internal Medicine|August 2, 2021
In premature ejaculation, SSRIs improve self-perceived symptoms and satisfaction vs. placeboRoger E Thomas
Journal of Medical Biography|January 16, 2002
The diagnosis and management of Crown Prince Friedrich's laryngeal tumourRoger E Thomas
Vaccine|December 3, 2014
Are influenza-associated morbidity and mortality estimates for those ≥ 65 in statistical databases accurate, and an appropriate test of influenza vaccine effectiveness?Roger E Thomas
Vaccine|March 4, 2014
Is influenza-like illness a useful concept and an appropriate test of influenza vaccine effectiveness?Roger E Thomas
Geriatrics (Basel, Switzerland)|February 9, 2021
Pneumococcal Pneumonia and Invasive Pneumococcal Disease in Those 65 and Older: Rates of Detection, Risk Factors, Vaccine Effectiveness, Hospitalisation and MortalityRoger E Thomas
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Current Aging Science|February 23, 2016
Assessing Medication Problems in those ≥ 65 Using the STOPP and START CriteriaRoger E Thomas
Vaccine|May 13, 2016
Do we have enough evidence how seasonal influenza is transmitted and can be prevented in hospitals to implement a comprehensive policy?Roger E Thomas
Journal of Travel Medicine|October 30, 2013
Can the safety of the yellow fever vaccine be evaluated by a retrospective study of databases?Roger E Thomas
Drug Design, Development and Therapy|October 28, 2016
Yellow fever vaccine-associated viscerotropic disease: current perspectivesRoger E Thomas
American Journal of Public Health|November 7, 2019
Roger E. Thomas CommentsRoger E Thomas
Annals of Internal Medicine|August 2, 2021
In premature ejaculation, SSRIs improve self-perceived symptoms and satisfaction vs. placeboRoger E Thomas
Journal of Medical Biography|January 16, 2002
The diagnosis and management of Crown Prince Friedrich's laryngeal tumourRoger E Thomas
Vaccine|December 3, 2014
Are influenza-associated morbidity and mortality estimates for those ≥ 65 in statistical databases accurate, and an appropriate test of influenza vaccine effectiveness?Roger E Thomas
Vaccine|March 4, 2014
Is influenza-like illness a useful concept and an appropriate test of influenza vaccine effectiveness?Roger E Thomas
Geriatrics (Basel, Switzerland)|February 9, 2021
Pneumococcal Pneumonia and Invasive Pneumococcal Disease in Those 65 and Older: Rates of Detection, Risk Factors, Vaccine Effectiveness, Hospitalisation and MortalityRoger E Thomas
Pageof 7